Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Announcements
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • Announcements

Editor-in-Chief: Giuseppe Leone | Italy

2.3
Impact Factor 2025
3.2
CiteScore 2025
2.3
Impact Factor 2025
3.2
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • Sickle cell disease and Bartonella spp. infection

    Paulo Eduardo Neves Ferreira Velho, Marna Elise Ericson, David Mair, Kalpna Gupta
    e2012046
    2012-06-30
    https://doi.org/10.4084/mjhid.2012.046
    1453
    PDF: 1473
    HTML: 531
  • Safety warning for ChAdOx1 nCov-19 vaccine in patients with sickle cell disease Astra Zeneca vaccine in Sickle cell disease (SCD)

    Salam Alkindi, Dr. , Dr.
    e2021059
    2021-09-01
    https://doi.org/10.4084/MJHID.2021.059
    2348
    PDF: 583
    HTML: 196
  • THE USE OF HPLC AS A TOOL FOR NEONATAL CORD BLOOD SCREENING OF HAEMOGLOBINOPATHY - A VALIDATION STUDY

    A. Al-Madhani, Anil Pathare, Salam Alkindi
    e2019005
    2019-01-01
    https://doi.org/10.4084/mjhid.2019.005
    2245
    PDF: 1279
    HTML: 427
  • Peripheral Red Blood Cell Split Chimerism as a Consequence of Intramedullary Selective Apoptosis of Recipient Red Blood Cells in a Case of Sickle Cell Disease

    Marco Marziali, Antonella Isgrò, Pietro Sodani, Javid Gaziev, Daniela Fraboni, Katia Paciaroni, Cristiano Gallucci, Cecilia Alfieri, Andrea Roveda, Gioia De Angelis, Luisa Cardarelli, Michela Ribersani, Marco Andreani, Guido Lucarelli
    e2014066
    2014-08-28
    https://doi.org/10.4084/mjhid.2014.066
    1806
    PDF: 1092
    HTML: 1903
    Untitled: 253
    Untitled: 226
  • COMPREHENSIVE REVIEW OF GENETIC AND EPIGENETICS REGULATION OF FETAL HEMOGLOBIN IN β-HEMOGLOBINOPATHIES: FROM MOLECULAR MECHANISMS TO CLINICAL APPLICATIONS HbF Genetics in Anemia

    Yousef Saeed Mohammad Abu Za’ror, Joseph Bagi Suleiman, Fatima Azzahra Delmani, Jehad Farouq Alhmoud, Amer Mohammad Ayasreh, Sarah Ihsan Al-wendawi, Maryam Azlan
    e2026046
    2026-04-30
    https://doi.org/10.4084/MJHID.2026.046
    1065
    PDF: 768
    HTML: 168
  • HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THALASSEMIA AND SICKLE CELL DISEASE: EXPERIENCE OF MEDITERRANEAN INSTITUTE OF HEMATOLOGY IN A MULTI-ETHNIC POPULATION.

    Marco Marziali, Antonella Isgrò, Javid Gaziev, Guido Lucarelli
    e2009027
    2009-12-26
    1835
    PDF: 775
    HTML: 2988
  • EVOLUTION OF HEMOGLOBINOPATHY PREVENTION IN AFRICA

    Slaheddine Fattoum
    e2009005
    2009-10-27
    1161
    PDF: 474
    HTML: 15084
  • BACK TO THE “GOLD STANDARD”: HOW PRECISE IS HEMATOCRIT DETECTION TODAY? Novel ImageJ-based approach for the precise hematocrit measurement

    Dr. Leonid Livshits, Ms. Tal Bilu, Ms. Sari Peretz, Prof. Anna Bogdanova, Prof. Max Gassmann, Dr. Harel Eitam, Prof. Ariel Koren, Prof. Carina Levin
    e2022049
    2022-06-29
    https://doi.org/10.4084/MJHID.2022.049
    2769
    PDF: 979
    HTML: 1273
  • THE EVOLVING PHARMACOTHERAPEUTIC LANDSCAPE FOR THE TREATMENT OF SICKLE CELL DISEASE

    Samir Ballas
    e2020010
    2020-01-01
    https://doi.org/10.4084/mjhid.2020.010
    3389
    PDF: 3218
    HTML: 1253
  • THE PRICE OF MERCY: COMMENT TO THE PAPER "PREVENTION OF BETA-THALASSEMIA IN NORTHERN ISRAEL - A COST-BENEFIT ANALYSIS” BY KOREN ET AL

    Eliezer Rachmilewitz
    e2014022
    2014-03-10
    https://doi.org/10.4084/mjhid.2014.022
    1616
    PDF: 1045
    HTML: 2139
  • IRON DEFICIENCY ANAEMIA AMONG PRE-SCHOOL CHILDREN WITH SICKLE CELL ANAEMIA: STILL A RARE DIAGNOSIS?

    Olufemi Samuel Akodu, Omolara Adeolu Kehinde, Ijeoma Nnena Diaku-Akinwumi, Olisamedua Fidelis Njokanma
    e2013069
    2013-11-07
    https://doi.org/10.4084/mjhid.2013.069
    1583
    PDF: 900
    HTML: 2966
    cover leer: 195
  • PROCALCITONIN AS A BIOMARKER OF BACTERIAL INFECTION IN SICKLE CELL VASO-OCCLUSIVE CRISIS.

    Dilip Kumar Patel, Manoj Kumar Mohapatra, Ancil George Thomas, Siris Patel, Prasanta Purohit
    e2014018
    2014-02-16
    https://doi.org/10.4084/mjhid.2014.018
    2202
    PDF: 1130
    HTML: 15751
    COVER LETTER: 259
  • VASCULAR ENDOTHELIAL GROWTH FACTOR IN CHILDREN WITH THALASSEMIA MAJOR PDF

    sameh samir fahmey, Hassan Naguib, sanna Abdelshafy, rasha Alashry
    e2013044
    2013-06-05
    https://doi.org/10.4084/mjhid.2013.044
    1452
    PDF: 942
    HTML: 1148
    Figure 1 the correlation between frequency of blood transfusion and serum vascular endothelial growth factor (VEGF).: 232
  • SEVERE LIVER IRON CONCENTRATIONS (LIC) IN 24 PATIENTS WITH ?-THALASSEMIA MAJOR: CORRELATIONS WITH SERUM FERRITIN, LIVER ENZYMES AND ENDOCRINE COMPLICATIONS

    Vincenzo De Sanctis
    e2018062
    2018-10-27
    https://doi.org/10.4084/mjhid.2018.062
    2979
    PDF: 1498
    HTML: 379
  • Screening and genetic diagnosis of Hemoglobinopathies in Southern and Northern Europe: Two examples

    Antonio Amato, Piero C Giordano
    e2009007
    2009-08-07
    1319
    PDF: 540
    HTML: 1223
    Amato1: 224
    Figure 2 A: Prospective (grey columns) versus retrospective prevention (black columns) among indigenous couples at risk (left) and immigrant couples (right). Among immigrant couples the prevention it is still largely retrospective, while for Italian coupl: 301
    jdoe, : 307
    Figure 2 b: Prospective (grey columns) versus retrospective prevention (black columns) among indigenous couples at risk (left) and immigrant couples (right). Among immigrant couples the prevention it is still largely retrospective, while for Italian coupl: 202
  • SURVIVAL PROBABILITY IN PATIENTS WITH SICKLE CELL ANEMIA USING THE COMPETITIVE RISK STATISTICAL MODEL

    Samir Ballas, Emilia Matos do Nascimento, PhD, Clarisse Lopes de Castro Lobo, MD, Basilio de Bragança Pereira, PhD
    e2019022
    2019-02-26
    https://doi.org/10.4084/mjhid.2019.022
    1715
    PDF: 1032
    HTML: 297
  • MODULATING EFFECT OF THE ?158 G? (C?T) XMN-1 POLYMORPHISM IN INDIAN SICKLE CELL PATIENTS

    Sanjay Pandey, Sweta Pandey, Rahasya Mani Mishra, Renu Saxena
    e2012001
    2012-01-15
    https://doi.org/10.4084/mjhid.2012.001
    1761
    PDF: 979
    HTML: 1462
    Table: 255
  • IRON CHELATION THERAPY IN THALASSEMIA SYNDROMES

    Paolo Cianciulli
    e2009034
    1407
    PDF: 667
    HTML: 2355
  • Major Artery Occlusion: a Rare Complication of Sickle Cell Disease

    Adnan Agha
    e2010007
    https://doi.org/10.4084/mjhid.2010.007
    1463
    PDF: 1134
    HTML: 4682
  • AGING WITH THALASSEMIA AND SICKLE CELL DISEASE: A GERONTOLOGICAL MODEL OF ACCELERATED MULTIMORBIDITY AND FUNCTION-CENTERED CARE BEYOND MIDLIFE Thalassemia and Sickle Cell Diseases: Effect of Aging

    Dr.Sophia Delicou, Dr.Ioannis Ilias, Dr.Athanasia Kapota, Dr.Elena Papatheodorou, Dr.Maria Moraki, Dr.Aikaterini Xydaki, Dr.Alexandra Mika, Dr.Panagiota Giannou, Dr.Irene Kouroukli, Dr.Theodoros Aforozis, Dr.Myrto Palkopoulou, Dr.Christos Savvidis, Dr.Iliana Mani, Prof.Constantina Aggeli, Prof. John Koskinas
    e2026039
    2026-04-30
    https://doi.org/10.4084/MJHID.2026.039
    683
    PDF: 672
    Suppl. Files: 89
    HTML: 177
  • Atypical evolution of a Vaso-Occlusive presentation in Sickle Cell Disease: lessons in diagnostic vigilance

    Cristina Giubbilei, Elena Angeli, Fiammetta Fossi, Agnese Baffioni, Ginevra Giustini, Valentina Carrai
    e2026042
    2026-04-30
    https://doi.org/10.4084/MJHID.2026.042
    316
    HTML: 628
    PDF: 212
  • THALIDOMIDE FOR PATIENTS WITH THALASSEMIA INTERMEDIA: A RETROSPECTIVE MULTICENTER CLINICAL STUDY

    Kun Yang, Yi Wu, Yali Zhou, Tianhong Zhou, Li Wang, Zhili Geng, Xiaolin Yin
    e2020021
    2020-04-27
    https://doi.org/10.4084/mjhid.2020.021
    2397
    PDF: 1346
    HTML: 437
  • HEMATOPOIETIC STEM CELL TRNSPLANTATION IN THALASSEMIA AND RELATED DISORDERS

    Emanuele Angelucci, Federica Pilo, Clara Targhetta, Martina Pettinau, Cristina Depau, Claudia Cogoni, Sara Usai, Mario Pani, Laura Dessì, Donatella Baronciani
    e2009015
    2030
    PDF: 543
    HTML: 4060
  • BACTERIAL INFECTIONS FOLLOWING SPLENECTOMY FOR MALIGNANT AND NONMALIGNANT HEMATOLOGIC DISEASES

    Giuseppe Leone, Eligio Pizzigallo
    e2015057
    2015-10-12
    https://doi.org/10.4084/mjhid.2015.057
    5277
    PDF: 2145
    HTML: 8841
  • ADULT SICKLE CELL ANAEMIA PATIENTS IN BONE PAIN CRISIS HAVE ELEVATED PRO-INFLAMMATORY CYTOKINES

    Adekunle Emmanuel Alagbe, John Ayodele Olaniyi, Oladapo Wale Aworanti
    e2018017
    2018-03-01
    https://doi.org/10.4084/mjhid.2018.017
    3137
    PDF: 1013
    HTML: 572
  • ADVERSE PREGNANCY OUTCOMES IN SICKLE CELL TRAIT: A PROSPECTIVE COHORT STUDY EVALUATING CLINICAL AND HAEMATOLOGICAL PARAMETERS IN POSTPARTUM MOTHERS AND NEW-BORNS. Sickle cell trait pregnancy and outcomes

    r. Salam Al-Kindi
    e2023002
    2022-12-31
    https://doi.org/10.4084/MJHID.2023.002
    1697
    PDF: 1362
    HTML: 572
  • Monocyte HLA-Dr Expression to Monitor Immune Response and Potential Infection Risks Following Vaso-Occlusive Crises in Patients with Sickle Cell Anemia Monocyte HLA-DR expression in SCA patients

    Romain Fort, Guillaume Monneret, Elie Nader, Giovanna Cannas, Philippe Connes, Fabienne Venet, Arnaud Hot
    e2022078
    2022-10-29
    https://doi.org/10.4084/MJHID.2022.078
    898
    PDF: 635
    HTML: 298
  • JADENU® SUBSTITUTING EXJADE® IN IRON OVERLOADED ?- THALASSEMIA MAJOR (BTM) PATIENTS: A PRELIMINARY REPORT OF THE EFFECTS ON THE TOLERABILITY, SERUM FERRITIN LEVEL, LIVER IRON CONCENTRATION AND BIOCHEMICAL PROFILES

    Vincenzo De Sanctis
    e2018064
    2018-10-27
    https://doi.org/10.4084/mjhid.2018.064
    2830
    PDF: 1294
    HTML: 457
  • ECONOMIC EVALUATION OF CHELATION REGIMENS FOR ?--THALASSEMIA MAJOR: A SYSTEMATIC REVIEW

    Jialian Li
    e2019036
    2019-06-24
    https://doi.org/10.4084/mjhid.2019.036
    2349
    PDF: 1550
    HTML: 267
  • Prospective, case-control study of serological response after two doses of BNT162b2 anti-SARS-CoV-2 mRNA vaccine in transfusion-dependent thalassemic patients

    NICOLA SGHERZA, Stefania Zucano, Angelantonio Vitucci, Antonio Palma, Francesco Tarantini, Daniela Campanale, Luigi Vimercati, Angela Maria Vittoria Larocca, Domenico Visceglie, Amalia Acquafredda, Angelo Ostuni, Daniela Di Gennaro, Carmen Vitucci, Silvio Tafuri, Pellegrino Musto
    e2022056
    2022-06-29
    https://doi.org/10.4084/MJHID.2022.056
    1323
    HTML: 328
    PDF: 581
  • PREVALENCE OF SICKLE CELL TRAIT IN THE SOUTHERN SUBURBS OF BEIRUT, LEBANON

    Abdel Badih El Ariss, Mohamad Younes, Jad Matar, Zeina Berjaoui
    e2016015
    2016-02-20
    https://doi.org/10.4084/mjhid.2016.015
    4345
    PDF: 1089
    HTML: 19286
51 - 81 of 81 items << < 1 2 
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.